Ursolic Acid Enhances Doxorubicin Cytotoxicity on MCF-7 Cells Mediated by G2/M Arrest
Abstract
Ursolic acid has been widely known to possess biological activity against numerous tumor cell lines. Previous studies revealed its cytotoxicity on several cancer cells in vitro by either inducing apoptosis or cell cycle modulation. This study was conducted to investigate ursolic acid’s cytotoxicity solely and in combination with a chemotherapeutic agent, doxorubicin, on MCF-7 breast cancer cells, followed by observation on its mechanism. Cytotoxicity of single and combinational treatment of ursolic acid and doxorubicin on MCF-7 breast cancer cells were conducted by using MTT assay. Single treatment was then evaluated by determining IC50 value, while combinational treatment was evaluated by analyzing cell viability and evaluating combination index (CI). To explore the mechanism underlying cytotoxic effect on respected cells, further analysis on cell cycle profile of single and combinational treatment was conducted by flow cytometry. Twenty four hours treatment of ursolic acid inhibited MCF-7 cells’ growth with IC50 value of 37 µM, while combinational treatment showed that several concentration combinations of ursolic acid and doxorubicin exhibited synergism of cytotoxic activity on MCF-7 cells, giving optimum CI value of 0.54. Flow cytometric analysis showed that combinational treatment induced G2/M arrest in MCF-7 cells. These results show that ursolic acid is promising to be developed as either single chemopreventive agent, or as doxorubicin’s co-chemotherapeutic agent in breast cancer treatment. Observation on the selectivity as part of safety aspect together with in silico, in vitro, and in vivo study on its molecular mechanism should be conducted.
Keywords: ursolic acid, doxorubicin,co-chemotherapeutic agent, breast cancer, cell cycle
Full Text:
PDFReferences
Bastl, A., Kaseirov, H., Den Hartog, G.J.M., Haenen, G.R.M.M. and Van Der Vijgh, W.J.F., 2007, Protectors Against Doxorubicin-Induced Cardiotoxicity: Flavonoids, Cell Biol. Toxicol., 23(1), 39-47. CrossRef
Childs, A.C., Phaneuf, S.L., Dirks, A.J., Phillips, T. and Leeuwenburgh, 2002, Doxorubicin Treatment In Vivo Causes Cytochrome c Release and Cardiomyocyte Apoptosis, as well as Increased Mitochondrial Efficiency, Superoxide Dismutase Activity, and Bcl-2:Bax Ratio, Cancer Res., 62(16), 4592-4598. Link
Davis, J.M., Navolonic, P.M., Weinstein, C.R., Steelman, L.S., Hu, Konovlepa, M.,et al., 2003, Raf-1 and Bcl-2 Induce Distinct dan Commn Pathway That Contribute to Cancer Drug Resistance, Clin. Cancer Res., 9(3), 1161-1170. Link
Drummond, C., 2007, The Mechanism of Anti-tumour Activity of the DNA Binding Agent SN 28049, Thesis, University of Auckland, New Zealand.
Fitriasari, A., Susidarti, R.A., and Meiyanto, E., 2010, Peningkatan Efek Sitotoksik Doxorubicin oleh Naringenin Melalui Pemacuan Apoptosis Sel Kanker Payudara MCF-7, Jurnal Bahan Alam Indonesia, 7(3), 165-170.
Foster, I., 2008, Cancer: A Cell Cycle Defect, Radiography, 14(2), 144-149. CrossRef
Hsu, Y. L., Kuo, P.K. and Lin, C. C., 2004, Proliferative Inhibition, Cell-Cycle Dysregulation, and Induction of Apoptosis by Ursolic Acid in Human Non-Small Cell Lung Cancer A549 Cells, Life Sci., 75(19), 2303-2316. CrossRef
Kassi, E., Sourlingas, T.G., Spiliotaki, M., Papoutsi, Z., Pratsinis, H., Aligiannis, N., et al., 2009, Ursolic Acid Triggers Apoptosis and Bcl-2 Downregulation in MCF-7 Breast Cancer Cells, Cancer Invest., 27(7), 723-733. CrossRef
Mechetner, E., Kyshtoobayeva A., Zonis S., Kim H., Stroup R., Garcia R., et al., 1998, Levels of Multidrug Resistance (MDR1) P-Glycoprotein Expression by Human Breast Cancer Correlate with in vitro Resistance to Taxol and Doxorubicin, Clin. Cancer Res., 4(2), 389-398. Link
Meiyanto, E., Hermawan, A. and Anindyajati, 2012, Natural Products for Cancer-Targeted Therapy: Citrus Flavonoids as Potent Chemopreventive Agents, Asian Pac. J. Cancer Prev., 13(2), 427-436. Link
Moynagh, P.N., 2005, The NF-ĸB Pathway, J. Cell Sci., 118, 4589-4592.
Notarbartolo, M., Poma, P., Perri, D., Dusonchet, L., Cervello, M. and D’Alessandro, N., 2005, Antitumor Effects of Curcumin, Alone or in Combination with Cisplatin or Doxorubicin, on Human Hepatic Cancer Cells: Analysis of Their Possible Relationship to Changes in NF-ĸB Activation Levels and in IAP Gene Expression, Cancer Lett., 224(1), 53-65. CrossRef
Reynolds, C.P. and Maurer B.J., 2005, Evaluating Response to Antineoplastic Drug Combinations in Tissue Culture Models, Methods in Mol. Med., 110, 173-183. CrossRef
Shah, M.A. and Schwart, G.K., 2006, Cyclin Dependent Kinases as Targets for Cancer Therapy, Update on Cancer Therapeutics, 1, 311-332.
Song, Y.H., Jeong, S.J., Kwon, H.Y., Kim, B., Kim, S.H. and Yoo, D.Y, 2012, Ursolic Acid from Oldenlandia diffusa Induces Apoptosis via Activation of Caspases and Phosphorylation of Glycogen Synthase Kinase 3 Beta in SK-OV-3 Ovarian Cancer Cells, Biol. Pharm. Bull., 35(7), 1022-1028. Link
Teng, W.Y., Huang, Y.L., Shen, C.C., Huang, R.L., Chung, R.S. and Chen, C.C., 2005, Cytotoxic Acridone Alkaloids from the Stem Bark of Citrus Maxima, J. Chin. Chem. Soc., 52(6), 1253-1255. CrossRef
Tian , Z., Lin, G., Zheng, R.X., Huang, F., Yang, M.S. and Xiao, P.G., 2006, Anti-hepatoma Activity and Mechanism of Ursolic Acid and Its Derivatives Isolated from Aralia decaisneana, World J. Gastroenterol, 12(6), 874-879. Link
Wang, J.S., Ren, T.N. and Xi, T., 2012, Ursolic Acid Induces Apoptosis by Suppressing the Expression of FoxM1 in MCF-7 Human Breast Cancer Cells, Med. Oncol., 29(1), 10-15. CrossRef
Wei, G., Wang, J. and Du, Y., 2011, Total Synthesis of Solamargine, Bioorg. Med. Chem. Lett., 21(10), 2930-2933. CrossRef
Zampieri, L., Bianchi, P., Ruff, P. and Arbuthnot, P., 2002, Differential Modulation by Estradiol of P-glycoprotein Drug Resistance Protein Expression in Cultured MCF7 and T47D Breast Cancer Cells, Anticancer Res., 22(4), 2253-2259. Link
Zhang , W., Li, Y., Zhang, G., Lu, J. and Ou, H., 2005, Experimental Study on MCF-7 Cell Apoptosis Induced by Ursolic Acid, Zhong Yao Cai, 28(4), 297-301. Link
DOI: http://dx.doi.org/10.14499/indonesianjcanchemoprev3iss3pp410-418
Copyright (c) 2017 Indonesian Journal of Cancer Chemoprevention
Indexed by:
Indonesian Society for Cancer Chemoprevention
